Encouraging news to hear that progress is being made on developing a vaccine against one type of lung cancer. The article states non-small cell lung cancer is the leading cause of cancer death in the U.S. with more than 150,000 people dying from the disease each year. But preliminary results, of a very small sample, indicates some success. Of the 43 patients in the study, three had full remission and seven had the disease stabilize and not increase in size.